Advertisement
Home Tags Heart / Stroke-Related: Heart Attack

Tag: Heart / Stroke-Related: Heart Attack

β-Blockers Not Beneficial After MI Without Reduced Left Ventricular Ejection Fraction

0

Second study shows beneficial effects for patients with myocardial infarction and mildly reduced LVEF

Women Have Worse Outcomes Than Men With Beta-Blockers After Acute MI

0

Incidence of primary end point of death, MI, heart failure hospitalization up with beta-blockers in women, but not in men

Liberal RBC Transfusion Strategy Suggested for Acute Myocardial Infarction

0

When hemoglobin concentration is <10 g/dL, liberal red blood cell transfusion strategy is suggested

Two Doses of Zoster Vaccine Reduce Risk for Herpes Zoster Ophthalmicus

0

In adults aged 50 years or older, two-dose recombinant zoster vaccine linked to reduced risk for HZO, acute myocardial infarction, stroke

Risk for Incident CVD Increased for Women Who Reported Experiencing Stalking

0

Increased risk for incident cardiovascular disease also seen for women who reported obtaining a restraining order

Nonlinear Inverse Association Seen for Step Count, Peak Cadence With MACE

0

Significantly lower risk for MACE, heart failure, myocardial infarction, stroke seen with each 1,000-step increase

Living in Marginalized Neighborhoods Linked to Adverse Outcomes in Acute MI

0

Increasing neighborhood marginalization linked to higher rates of mortality beginning at 30 days after discharge

Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction

0

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function

P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI

0

Risk for major adverse cardiac and cerebrovascular events lower compared with aspirin monotherapy for patients who undergo PCI and discontinue DAPT

Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction

0

In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins